Latest News

aPROMISE was developed to quantify and standardize assessment of PSMA PET/CT images and will support PYLARIFY® (piflufolastat F 18) adoption in the U.S. San Francisco, CA (UroToday.com) — Lantheus Holdings, Inc. (Lantheus) announced that its subsidiary, EXINI Diagnostics AB, was granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its digital application, aPROMISE™ (automated PROstate […]

(UroToday.com) The 2021 American Urological Association (AUA) Summer School session on Upper Tract Urothelial Carcinoma included a case-based discussion led by moderator Dr. Surena Matin who was joined by panelists Dr. Sima Porten and Dr. Vitaly Margulis. This case highlighted the diagnosis and treatment of upper tract urothelial carcinoma in patients with suspicion for hereditary disease. […]

(UroToday.com) The 2021 American Urological Association (AUA) Summer School session on Upper Tract Urothelial Carcinoma included a case-based discussion led by moderator Dr. Surena Matin who was joined by panelists Dr. Sima Porten and Dr. Vitaly Margulis. Upper tract urothelial carcinoma accounts for 5-10% of all urothelial cancers, with an incidence of 2 per 100,000 people […]

(UroToday.com) The 2021 American Urological Association (AUA) Summer School session on Upper Tract Urothelial Carcinoma included a case-based discussion led by moderator Dr. Surena Matin who was joined by panelists Dr. Sima Porten and Dr. Vitaly Margulis. This case discussed high-risk ureteral urothelial carcinoma within the setting of node-positive disease. The patient was a 49-year-old male […]

(UroToday.com) The 2021 American Urological Association (AUA) Summer School session on Upper Tract Urothelial Carcinoma included a case-based discussion led by moderator Dr. Surena Matin who was joined by panelists Dr. Sima Porten and Dr. Vitaly Margulis. This case highlighted high-risk upper tract urothelial carcinoma in a solitary kidney with synchronous bladder urothelial carcinoma. The patient […]

(UroToday.com) The 2021 American Urological Association (AUA) Summer School session on Upper Tract Urothelial Carcinoma included a case-based discussion led by moderator Dr. Surena Matin who was joined by panelists Dr. Sima Porten and Dr. Vitaly Margulis. This case highlighted the treatment of Jelmyto (mitomycin) treatment for upper tract urothelial carcinoma. This patient was a 56-year-old […]

(UroToday.com) The 2021 American Urological Association (AUA) Summer School session on Upper Tract Urothelial Carcinoma included a case-based discussion led by moderator Dr. Surena Matin who was joined by panelists Dr. Sima Porten and Dr. Vitaly Margulis. This case highlighted the management of upper tract urothelial carcinoma with node positive disease and a low eGFR. The […]

The “abscopal effect” in cancer is frequently discussed, although very rarely seen.  While the term is used quite loosely, it technically is a situation where an untreated metastatic tumor will shrink concurrently while another site is undergoing a localized treatment.  Most commonly, radiation therapy is referenced as that local treatment.  Although the exact mechanism is […]

Kidney stone disease seems to be associated with an increased risk of incident cardiovascular outcomes; the aim of this study is to identify differences in 24-h urine excretory profiles and stone composition among stone formers with and without cardiovascular disease (CVD).

To evaluate the characteristics of urinary stone composition in a Korean population using a large database of stone composition. From January 1, 2014, to June 30, 2019, a total of 33,078 urinary stone composition data were analyzed.